Artificial intelligence (AI) is transforming various domains of human activity, including health care. AI can assist in diagnosis, treatment, monitoring, and prevention of diseases, as well as in enhancing the quality and efficiency of health care delivery. However, AI also poses some challenges and risks, such as ethical, legal, and social implications, data privacy and security, and human-AI interaction.
Tag Archive for: healthcare providers
The U.S. Centers for Disease Control and Prevention has issued an advisory alerting healthcare providers about an increase in invasive meningococcal disease and urging them to ensure necessary vaccinations against the deadly disease.
How pharma companies can communicate effectively in today’s evolving marketplace and why it is the right time to embrace our humanity when engaging various stakeholders along the product, patient, and reimbursement/coverage journeys.
In a strategic move aimed at fortifying brand positioning and driving global growth, Doceree has enlisted the expertise of two industry luminaries: the former chief marketing officer= of DeepIntent and former managing director of the renowned IPG Group agency.
Ashfield Event Experiences, part of Inizio Engage XD, has teamed up with the IPCAA (International Pharmaceutical Congress Advisory Association) to address how healthcare provider (HCP) behaviors and attitudes towards medical congresses and conventions have been impacted by the return of in-person events.
If you represent or support a pharmaceutical manufacturer, chances are good you’ve seen all the conversation around biosimilars heating up. In July alone, we saw an unprecedented number (seven!) of biosimilars for Humira launch simultaneously. Interestingly, though, if you look at the conversation going on in the marketplace, the bulk of the discussion about which will be adopted and why is focused on behind-the-scenes pricing. However, as many recent reports and our experience indicate, that’s not really what’s standing in the way of adoption.
The pharmaceutical industry is finally embracing the idea of engaging with key digital opinion leaders (DOLs) to aid in disseminating information, raising awareness, and educating healthcare professional (HCP) peers in their field. Many articles and case studies have been written about identifying DOLs, mapping their influence, and matching the right DOL to the right campaign. In the past year, an increasingly larger number of medical and commercial teams at pharmaceutical companies have begun to execute these campaigns. The question many companies are now asking is: How do we measure the effectiveness of these DOL efforts?
A nationally representative survey of 2,001 employed adults in the United States released by the health insurance company Aflac found that many — one in four — simply skip regular checkups because they are feeling healthy. According to the survey, about half of adults have avoided at least one common health screening, including tests for certain diseases and other exams.
